With waning Covid-19 and flu vaccination rates globally, it’s clear that vaccine manufacturers need to get more creative if they don’t want their vaccines left sitting in warehouses instead of in arms. Some vaccine manufacturers have already started combining seasonal flu vaccines into one syringe.
Korea Biomedical Review is publishing a series of articles to analyze the top 10 Korean pharmaceutical and biopharma companies with the largest market capitalizations listed on the main bourse, Kospi, and the tech-heavy Kosdaq. The series aims to reflect key industrial issues and the flow of the cap
Contraceptives were once a taboo topic but as they became more widely used in society, they gradually became easier to discuss, especially as they are now employed as a life-saving treatment in some cases. Still, the term is mostly associated with females as contraceptive options for males remain li
SAN FRANSICO, Calif. -- By Lee Han-soo/Korea Biomedical Review correspondent – SCM Lifescience said it would develope SCM-AGH as a first-in-class treatment for acute pancreatitis, which there are currently no suitable treatment options.Korea Biomedical Review sat down with SCM Lifescience CEO Son By
As much as Hallyu might be enough to draw foreigners into Korea, many essential services in the country like hospitals and banks still lack sufficient English services necessary to keep foreigners in Korea long term.Foreigners who live in Korea are well aware of this struggle. Commenting on the issu
SAN FRANCISCO, Calif. -- By Lee Han-soo/Korea Biomedical Review correspondent – ABL Bio said it would seek licensing-out deals for two bispecific antibody oncology candidates, taking advantage of its $1 billion mega-deal with Sanofi during 2022 J.P. Morgan Healthcare Conference a year earlier.In Jan
SAN FRANCISCO, Calif. -- By Lee Han-soo/Korea Biomedical Review correspondent – As the Covid-19 pandemic is transitioning into an endemic, many healthcare companies unveiled their blueprint to expand their business to the global stage at the 2023 J.P. Morgan Healthcare Conference.Unlike in the past
All human beings possess 99.9 percent identical genes and yet, there are a million differences that cause individuals to respond differently to diseases and treatments. There are already personalized immunotherapies and very soon, a specially custom-made mRNA cancer vaccine might also be on the hori
SAN FRANCISCO, Calif. -- By Lee Han-soo/Korea Biomedical Review correspondent – Healthcare providers and innovative companies are turning to digital healthcare as a solution to address the vulnerable medical systems such as physician burnout and healthcare access inequality.Korea Biomedical Review m
SAN FRANCISCO, Calif. -- By Lee Han-soo/Korea Biomedical Review correspondent – Lotte Biologics announced its full-fledged advancement as a CDMO (contract development and manufacturing organization) and its mid-to-long-term vision at the JP Morgan Healthcare Conference’s Asia Pacific Track on Tuesda
SAN FRANCISCO, Calif. -- By Lee Han-soo/Korea Biomedical Review correspondent – Despite having acquired Meridian Bioscience, a global multinational diagnostic company, and posting nearly 3 trillion won ($2.49 billion) in sales in 2022, investors’ interest in SD Biosensor seems to have faded.The corp
SAN FRANSICO, Calif. -- By Lee Han-soo/Korea Biomedical Review correspondent – Orum Therapeutics, a Korean biotech start-up, is drawing attention at 2023 J.P. Morgan Healthcare Conference because it is conducting U.S. clinical trials of an anticancer drug using a new concept that merges targeted pro
SAN FRANSICO, Calif. -- By Lee Han-soo/Korea Biomedical Review correspondent – The J.P. Morgan Healthcare Conference 2023 kicked off its four-day run at the Westin St. Francis San Francisco on Monday. Investors attending the event said they would look into the balance sheets of biopharmaceutical com
The mRNA platform will continue to grab headlines for a while as it made history thanks to Moderna and Pfizer producing the world’s first and fastest Covid-19 vaccines using the mRNA platform. Of course, producing a vaccine in just 11 months is no small feat when compared to the usual 10-15 years re
In Korea, even daytime drinking on the job can be considered normal depending on where you work. Interestingly, however, when it comes to smoking, the same laissez-faire attitude is not adopted.However, they are both labeled as Group 1 carcinogens by the World Health Organization (WHO). Still, only
On all counts, 2022 marked yet another memorable year for Korea’s bioindustry. Stories related to Covid-19 regarding quarantine and mask mandates garnered a lot of interest from our viewers as quarantine officials adopted a phased approach to relaxing mandates throughout the year.Of particular note
In Korea, a country well-known for its wide variety of pork dishes ranging from the famous samgyeopsal, bossam and jeyuk bokkeum, Muslims and vegans living in Korea are used to carefully reading the labels of anything they consume as many products often contain animal products. However, when it come
The healthcare consulting business has witnessed rapid growth in recent years as increased access to health coverage and the development of new technologies have resulted in new challenges for healthcare providers and pharmaceutical companies.KPMG Healthcare is one of the leading global professional
Korean dental clinics, equipped with the superior technology and low-cost services, are gearing up to attract foreign patients amid the eased Covid-19 pandemic.Especially after Korea lifted all the quarantine restrictions for travelers entering Korea, the Korea Health Industry Development Institute
Many might be surprised to learn that companies like Uber were once small start-ups. Similarly, in the medical space, technology-driven healthcare solutions have seen rapid growth with the explosion of artificial intelligence (AI) boosting the success of Korean companies like VUNO, Lunit, and 3billi